Seer (SEER) Net Margin Growth (1y) (2021 - 2026)

Seer (SEER) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -763.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 447.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 673.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,097.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -392.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2,208.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,636.00
10 Seer 230.63 Mn 230.63 Mn 1.51 Mn -6,529.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -6,529.00
Mar 31, 2026 -12,844.00
Dec 31, 2025 16,903.00
Sep 30, 2025 8,650.00
Jun 30, 2025 26,433.00
Mar 31, 2025 20,007.00
Dec 31, 2024 -13,283.00
Sep 30, 2024 88,809.00
Jun 30, 2024 -6,173.00
Mar 31, 2024 89,470.00
Dec 31, 2023 7,222.00
Sep 30, 2023 -54,014.00
Jun 30, 2023 5,263.00
Mar 31, 2023 42,233.00
Dec 31, 2022 15,394.00
Sep 30, 2022 131,900.00
Jun 30, 2022 79,175.00
Mar 31, 2022 2.75 Mn
Dec 31, 2021 320,424.00
Sep 30, 2021 923,325.00